非阿片类药物用于急性护理环境中的阿片类药物戒断管理:范围审查
Brian L Erstad1, Aurora N Quaye2, Megan E Hellwege3
1Department of Pharmacy Practice and Science, University of Arizona R. Ken Coit College of Pharmacy, Tucson, AZ, USA.
概括
非阿片类药物可能有助于管理住院患者急性阿片类药物戒断. 阿尔法上腺素受体激动剂显示出最有前途的效果,但需要更多的研究才能得出关于有效性和安全性的最终结论.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
- 成 药物 药物 药物 药物
背景情况:
- 患有慢性阿片类药物使用的住院患者可能会经历阿片类药物戒断.
- 一些患者在住院期间不能或不想使用阿片类药物治疗阿片类药物使用障碍 (OUD).
研究的目的:
- 评估非阿片类药物的有效性和安全性,用于急性阿片类药物戒断管理在急性护理设置.
- 为希望避免使用阿片类药物的阿片类药物使用障碍 (OUD) 患者确定潜在的替代治疗方法.
主要方法:
- 在PubMed,Embase和Cochrane图书馆数据库中进行了全面的文献搜索,直到2024年.
- 还审查了相关全文文章的文献,以确定其他研究.
主要成果:
- 确定了28项针对急性阿片类药物戒断的非阿片类药物的研究.
- 药物按机制分类:α-上腺激动剂,NMDA对抗剂,GABA调节剂和血清激活剂.
- 阿尔法-上腺素受体激动剂 (克罗尼丁,洛菲克西丁) 显示了最多的疗效证据,尽管研究存在局限性.
结论:
- 在急性阿片类药物戒断中,α-上腺体受体激剂似乎比NMDA对抗剂,GABA调节剂或血清激素药物更有效.
- 为了确定非阿片类药物替代品在临床决策中的有效性和安全性,需要进一步的研究.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
223
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
223
Analgesia and Pain Management
504
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
504
Opioid Analgesics: Morphine and Other Natural Cogeners
183
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
183
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
174
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
174
Opioid Receptors: Overview
521
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
521
Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147


